參考文獻 |
1. Gallagher C, Elliott AD, Wong CX, RangnekarG, MiddeldorpME, MahajanR, Lau DH, Sanders P, HendriksJML. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart 2017;103:1947–1953. (Oxford level of evidence, 2011:Level 1) 2.NtaiosG,PapavasileiouV,MakaritsisK,VemmosK, Michel P, Lip GYH. Realworldsetting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Stroke 2017;48:2494–2503. (Oxford level of evidence, 2011:Level 1) 3. Gallagher C, Elliott AD, Wong CX, RangnekarG, MiddeldorpME, MahajanR, Lau DH, Sanders P, HendriksJML. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart 2017;103:1947–1953. (Oxford level of evidence, 2011:Level 1) 4. Tim Hicks, Fiona Stewart and Anne Eisinga. NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis. Open Heart 2016;3:e000279 (Oxford level of evidence, 2011:Level 1) |